Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients
Author:
Funder
Finnish Cancer Society
Oulu University
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/article/10.1007/s00432-018-2682-9/fulltext.html
Reference29 articles.
1. Baron KB, Brown JR, Heiss BL, Marshall J, Tait N, Tkaczuk KHR et al (2014) Trastuzumab-induced cardiomyopathy: Incidence and associated risk factors in an inner-city population. J Card Fail 20(8):555–559. https://doi.org/10.1016/j.cardfail.2014.05.012
2. Baselga J, Cortés J, Kim S, Im S, Hegg R, Im Y et al (2012) Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 366(2):109–119. https://doi.org/10.1056/NEJMoa1113216
3. Bowles EJA, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T et al (2012) Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst 104(17):1293–1305. https://doi.org/10.1093/jnci/djs317
4. Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM et al (2001) Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol 19(10):2722–2730. https://doi.org/10.1200/JCO.2001.19.10.2722
5. Cardinale D, Colombo A, Torrisi R, Sandri MT, Civelli M, Salvatici M et al (2010) Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol 28(25):3910–3916. https://doi.org/10.1200/JCO.2009.27.3615
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): a pharmacovigilance study based on the FAERS database;Frontiers in Pharmacology;2024-05-03
2. Pioneering the Way: The Revolutionary Potential of Antibody–Drug Conjugates in NSCLC;Current Treatment Options in Oncology;2024-03-23
3. Case report: Urothelial injury in a female with breast cancer: a rare adverse event after the combination of paclitaxel and trastuzumab;Frontiers in Oncology;2024-01-18
4. Late-onset cardiotoxicity in patients with HER2-positive metastatic breast cancer receiving trastuzumab-based therapy;Journal of Oncology Pharmacy Practice;2023-08-01
5. Risk of myocardial infarction and stroke after female breast cancer: analysis on a cohort of 1.3 million women;2023-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3